Dow Up 0.08% Nasdaq Down 0.30%

Vanda Pharmaceuticals, Inc. (VNDA)

-NasdaqGM
12.00 Down 0.40(3.23%) Sep 19, 4:00PM EDT
|After Hours : 12.00 0.00 (0.00%) Sep 19, 4:40PM EDT
Prev Close:12.40
Open:12.51
Bid:11.00 x 600
Ask:12.56 x 100
1y Target Est:27.50
Beta:2.17
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:11.84 - 12.59
52wk Range:5.70 - 19.25
Volume:920,910
Avg Vol (3m):543,403
Market Cap:406.52M
P/E (ttm):N/A
EPS (ttm):-1.34
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
VNDADown 3.23%406.52M
AZNUp 0.76%94.37B
LLYDown 0.09%71.30B
JNJUp 0.60%304.56B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.20
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.00
Quarterly EPS Est (Sep-14) :-0.39
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.38

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Vanda Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development and commercialization of pharmaceutical products. Its product portfolio includes HETLIOZ, a product for the treatment of Non-24-Hour Sleep-Wake Disorder; Fanapt... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback